Amarin Corp Plc (AMRN)

[jessellivermore]

Card...

I know no doctor writes indications on the script I have been a clinician for forty years...
You don;t understand what I am saying ,,the indication does not mean anything..The only thing that counts is whether its the brand drug or the generic because in this scenario the Brand can use both the Marine indication and the R-I label indication...And doctors will for the most part be writing it for CVD event risk...The generic can not by law write for any other indications than trig lowering (the MARINE label) and there are drugs in that space that are cheaper..There is no cheaper drug in the R=I indication.

Just because a doctor writes a script using the generic for the CVD label indication does not mean the Drug plans are going to be treating it like a CVD drug. They will treat it like a MARINE Drug as that is the only condition the generic is legally indicated for...This was the same thing last year for Amarin...Doctors wrote the V script off label for its cardiac benefits...But the Drug plans treated it as a high trig drug because that was the only indication on the label. The company did not get the expanded label until the end of December,.Since there were other trig lowering drugs that were cheaper than Vascepa. Drugs like Lovaza.. is why Vascepa was Tier four on most drug plans..And the company could do very little to correct that...

":>) JL